Deepbridge Capital

Deepbridge operates 4 EIS/SEIS Funds across the technology and life sciences sectors; Deepbridge Technology Growth EIS, Deepbridge Life Sciences EIS, Deepbridge Innovation SEIS and Deepbridge Life Sciences SEIS.

Share this project

These Funds allow Deepbridge to fund companies from pre-seed to Series A stage, with recognition of the importance of continuity of capital to the journey of such companies.

At the pre-seed/seed stage, we seek highly disruptive companies with sector expert founders, with a clear opportunity to scale and protect IP. At EIS stage, we expect companies to have a degree of traction. This could be initial commercial revenues, a key strategic partner or clinical buy-in, depending on the sector.

Sectors we have invested in include FinTech, automotive tech, sustainable tech, drug discovery, therapeutics, healthcare tech, medtech, AI, VR/AR, Blockchain, space tech, biotech, Agritech and more.

Dealflow is sourced from numerous partners and contacts, with spinouts from 17 different universities within the portfolio.

Using a clear rating system, linked with our ESG screening, all deals are evaluated on a quantitative basis, with value proposition, IP and team experience key drivers. This is supported by other factors relating to competition/disruption of the innovation, scalability, commercial traction and future exit opportunities. We also have metrics and a review process in place to minimise any unconscious bias and reward gender and ethnic diversity of the founding team.

The Deepbridge approach to supporting investees has always been focused on providing practical, hands-on guidance and management. This may include supporting the founders to develop a C-suite and Board with the necessary skills and experience. Our focus is then to ensure companies have robust governance and reporting, with a future eye always on ensuring companies are investor ready and able to attract co-funding — with syndication a key priority.

Depending on requirements, our team will provide commercial guidance to scientific-led founders and provide specific support including sales and marketing support, website development, accounting guidance and strategy input. Our key role is to provide both backing and to challenge management teams ensuring that the appropriate focus is adopted, which can often mean identifying the appropriate use or market for an innovation. Whilst syndication on deals is important, Deepbridge prefers to lead rounds in order to ensure that our active management style is adopted.


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.